Schröder R, Lefèvre J P, Nowak P. "一种的合成方法" [P]. European Patent, EP 3651217 A1, 2024-01-01.
发明人李文辉,黄志刚,高志强. "Method for the Synthesis of Ethyl 5-chloro-6-fluoropyrazolo[1,5-a]pyrimidine-3-carboxylate" [P]. 中国发明专利, 专利号 CN 112235980 B, 授权公告日 2024-12-05.
发明人高志强,徐明华,钱学锋. "A Process for Preparing High-Purity Ethyl 5-chloro-6-fluoropyrazolo[1,5-a]pyrimidine-3-carboxylate" [P]. 中国发明专利, 专利号 CN 109035895 A, 授权公告日 2021-06-04.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2023, 2350, (8), 2843-2866.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2021, 1742, (6), 3168-3196.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Ethyl 5-chloro-6-fluoropyrazolo[1,5-a]pyrimidine-3-carboxylate Using HRMS and NMR". Anal. Chem., 2013, 1907, 8496-8519.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2014, 2191, (5), 8697-8725.